drugset / Trial / NCT00002443

The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002443

Completed 780 enrolled Merck Sharp & Dohme LLC
Double-blindTreatment

Summary

To compare the effects on CD4 counts and safety of MK-639 (indinavir, IDV) and AZT administered concomitantly to MK-639 alone and AZT alone in HIV-1 seropositive patients.

Timeline

Start
Primary completion
Completion
1996-01

Drugs

EvaluationDrugModalityDoseRoute
Subject INDINAVIR ANHYDROUS Other / unclassified
Subject Zidovudine Small molecule